Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2014 Mar;21(3):383–390. doi: 10.1128/CVI.00594-13

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2014, American Society for Microbiology. All Rights Reserved.

The authors have paid a fee to allow immediate free access to this article.

PMC Copyright notice

FIG 6 — Two groups of chimpanzees (group 1, chimps no. 329 and 338; group 2, chimps no. 1,475 and 1,479) were immunized with live RSV-MARM-1142 by combined intranasal/intratracheal installation or inoculated with vaccinia-RSV-F and vaccinia-RSV-G viruses, respectively, and then challenged with live RSV-A2 using combined intranasal/intratracheal installation of the virus. Preimmune, postimmunization, and postchallenge antisera were tested for anti-RSV-N-specific IgG antibodies using the LIPS-N_RSV assay. (A) Group 1 chimps were seronegative prior to immunization but showed a positive anti-RSV-N IgG response following administration of RSV-MARM-1142 and had a boost in the IgG response following infection with RSV-A2. (B) Group 2 chimps were seronegative prior to immunization and showed no anti-RSV-N-specific IgG antibody response following inoculation with vaccinia-RSV-F and vaccinia-RSV-G viruses. However, anti-RSV-N IgG responses were detected following challenge with RSV-A2.